| Date | Title | Description |
| 15.11.2024 | Navigating the Waters of Corporate Finance: A Look at Recent Rights Issues | In the world of corporate finance, rights issues are like lifebuoys tossed to a ship in stormy seas. They offer companies a chance to raise capital, but they also come with deadlines and decisions that can make or break investor confidence.... |
| 11.11.2024 | The exercise period for CLS warrants of series TO 7 begins today | The exercise period for CLS warrants of series TO 7 begins today
Mon, Nov 11, 2024 09:03 CET Report this content
In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrant... |
| 10.11.2024 | Crunchfish's Rights Issue: A Strategic Move in a Competitive Landscape | Crunchfish AB is making waves in the financial waters with its latest rights issue. The company, known for its innovative technology in offline payments, is set to raise approximately SEK 57 million. This move comes at a time when the tech ... |
| 07.11.2024 | Roc Oil Company Pty Limited publishes a supplement to the offer document for the recommended cash offer to the shareholders of Tethys Oil AB | Roc Oil Company Pty Limited publishes a supplement to the offer document for the recommended cash offer to the shareholders of Tethys Oil AB
Thu, Nov 07, 2024 10:30 CET Report this content
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY... |
| 06.11.2024 | The subscription period in Crunchfish’s rights issue begins today and the company invites to a webinar about the rights issue | The subscription period in Crunchfish’s rights issue begins today and the company invites to a webinar about the rights issue
Wed, Nov 06, 2024 08:30 CET Report this content
Today, November 6th, 2024, the subscription period in Crunchfish A... |
| 30.10.2024 | ODI Pharma AB decides on a preferential issue of shares and to bring forward publication of the Q1-report | ODI Pharma AB decides on a preferential issue of shares and to bring forward publication of the Q1-report
Wed, Oct 30, 2024 15:40 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNI... |
| 25.10.2024 | Roc Oil Company Pty Limited publishes the offer document for the recommended cash offer to the shareholders of Tethys Oil AB | Roc Oil Company Pty Limited publishes the offer document for the recommended cash offer to the shareholders of Tethys Oil AB
Fri, Oct 25, 2024 10:20 CET Report this content
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, ... |
| 28.09.2024 | The Final Countdown: Warrant Expirations and Market Movements | The world of finance is a dance of numbers and timing. Investors are always on the lookout for opportunities, and warrants can be a golden ticket. But like all good things, they come with an expiration date. Recently, two companies, Phase H... |
| 26.09.2024 | The last day of trading in warrants of series TO 4 is on 1 October 2024 | The last day of trading in warrants of series TO 4 is on 1 October 2024
Thu, Sep 26, 2024 09:33 CET Report this content
The 1st of October 2024 is the last day of trading in warrants of series TO 4, which were issued in connection with Phas... |
| 20.09.2024 | Navigating the Warrant Landscape: A Look at Brain+ and Diagonal Bio | In the world of finance, warrants are like keys to a treasure chest. They offer investors the chance to unlock new shares at a predetermined price. Recently, two companies, Brain+ A/S and Diagonal Bio AB, have made headlines with their warr... |
| 19.09.2024 | The last day of trading in warrants of series TO 1 is on the 24th of September 2024 | The last day of trading in warrants of series TO 1 is on the 24th of September 2024
Thu, Sep 19, 2024 08:30 CET Report this content Read original
The 24th of September 2024 is the last day of trading in warrants of series TO 1, which were i... |
| 14.09.2024 | Curasight and Brain+: Navigating the Waters of Rights Issues and Warrants | In the bustling world of biotech, companies often seek new avenues for funding. Two Danish firms, Curasight A/S and Brain+ A/S, recently made headlines with their respective rights issues and warrant exercises. These financial maneuvers are... |
| 12.09.2024 | The exercise period for warrants of series TO 4 commences today | The exercise period for warrants of series TO 4 commences today
Thu, Sep 12, 2024 08:55 CET Report this content
Today is the first day for the exercise of Phase Holographic Imaging PHI AB's ("PHI" or "Company") warrants ... |
| 12.09.2024 | Curasight A/S publishes prospectus due to upcoming rights issue | Curasight A/S publishes prospectus due to upcoming rights issue
Thu, Sep 12, 2024 12:22 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, C... |
| 12.09.2024 | The exercise period for warrants of series TO 1 commences today | The exercise period for warrants of series TO 1 commences today
Thu, Sep 12, 2024 08:30 CET Report this content Read original
Today is the first day for the exercise of Diagonal Bio AB's ("Diagonal Bio" or "the Company")... |
| 11.09.2024 | Navigating the Warrant Landscape: A Look at Diagonal Bio and PHI | In the world of biotechnology, warrants can be a double-edged sword. They offer potential, but they also come with risks. Recently, two companies, Diagonal Bio AB and Phase Holographic Imaging (PHI) AB, announced the exercise prices for the... |
| 11.09.2024 | The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share | The exercise price for warrants of series TO 1 has been set to SEK 0,05 per new share
Wed, Sep 11, 2024 09:00 CET Report this content Read original
Diagonal Bio AB ("Diagonal Bio" or "the Company") hereby announces that ... |
| 11.09.2024 | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share | The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share
Wed, Sep 11, 2024 09:36 CET Report this content
Phase Holographic Imaging PHI AB ("PHI" or "the Company") hereby announces that the ex... |
| 26.06.2024 | Bio-Works Technologies resolves on fully secured rights issue of approximately SEK 39 million and announces intention to change listing venue to Spotlight Stock Market | Bio-Works Technologies resolves on fully secured rights issue of approximately SEK 39 million and announces intention to change listing venue to Spotlight Stock Market
Wed, Jun 26, 2024 18:00 CET Report this content
THIS PRESS RELEASE MAY N... |
| 24.06.2024 | Brain+ obtains additional guarantee commitment in its ongoing rights issue | Brain+ obtains additional guarantee commitment in its ongoing rights issue
Mon, Jun 24, 2024 10:06 CET Report this content
Copenhagen, Denmark, 24 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S (“Brain+” or the “Company”) an... |
| 21.06.2024 | Last day for subscription in the ongoing rights issue | Last day for subscription in the ongoing rights issue
Fri, Jun 21, 2024 08:45 CET Report this content
Copenhagen, Denmark, 21 June, 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR IND... |
| 20.06.2024 | Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue | Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue
Thu, Jun 20, 2024 12:37 CET Report this content
Copenhagen, Denmark, 20 Jun... |
| 20.06.2024 | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue | Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue
Thu, Jun 20, 2024 14:00 CET Report this content
Clinical Laserthermia Systems AB (publ) (“CLS” or the ”Company”) has drafted a supplementary pro... |
| 20.06.2024 | Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue | Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue
Thu, Jun 20, 2024 13:50 CET Report this content
The company an... |
| 13.06.2024 | The last day of trading in warrants of series TO 3 is on the 17th of June 2024 | The last day of trading in warrants of series TO 3 is on the 17th of June 2024
Thu, Jun 13, 2024 08:45 CET Report this content
The 17th of June 2024 is the last day of trading in warrants of series TO 3, which were issued in connection with... |
| 11.06.2024 | DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today | DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today
Tue, Jun 11, 2024 08:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO... |
| 11.06.2024 | The subscription period in Brain+ unit rights issue begins today | The subscription period in Brain+ unit rights issue begins today
Tue, Jun 11, 2024 08:47 CET Report this content
Copenhagen, Denmark, 11 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIREC... |
| 10.06.2024 | CLS publishes prospectus in connection with forthcoming rights issue | CLS publishes prospectus in connection with forthcoming rights issue
Mon, Jun 10, 2024 17:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES O... |
| 05.06.2024 | The exercise period for warrants of series TO 3 commences today | The exercise period for warrants of series TO 3 commences today
Wed, Jun 05, 2024 08:30 CET Report this content
Today is the first day for the exercise of Carbiotix AB's ("Carbiotix" or "Company") warrants of series TO 3... |
| 04.06.2024 | Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue | Brain+ A/S informs of the last day of trading in its shares including preferential rights to subscribe in the upcoming unit rights issue
Tue, Jun 04, 2024 08:30 CET Report this content
Copenhagen, Denmark, 4 June 2024 – Brain+ A/S (Nasdaq F... |
| 03.06.2024 | The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share | The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share
Mon, Jun 03, 2024 19:00 CET Report this content
Carbiotix AB ("Carbiotix" or "the Company") hereby announces that the exercise price f... |
| 31.05.2024 | Brain+ A/S: Publication of investment brochure | Brain+ A/S: Publication of investment brochure
Fri, May 31, 2024 13:59 CET Report this content
Copenhagen, Denmark, 31 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
The Board of Directors of Brain+ A/S (“Brain+” or the “Company”) decid... |
| 30.05.2024 | CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m | CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
Thu, May 30, 2024 18:20 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ... |
| 07.05.2024 | Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan | Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan
Tue, May 07, 2024 08:52 CET Report this content
Copenhagen, Denmark, 7 May 202... |
| 23.04.2024 | BoMill publishes prospectus regarding the Rights Issue | BoMill publishes prospectus regarding the Rights Issue
Tue, Apr 23, 2024 16:44 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HO... |
| 17.04.2024 | Last day for trading in BoMill's shares including the right to participate in the share issue | Last day for trading in BoMill's shares including the right to participate in the share issue
Wed, Apr 17, 2024 08:30 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN... |
| 12.04.2024 | Communiqué from Annual General Meeting in BoMill AB | Communiqué from Annual General Meeting in BoMill AB
Fri, Apr 12, 2024 10:58 CET Report this content
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG ... |
| 08.04.2024 | The subscription period in Diagonal Bio AB rights issue commences today | The subscription period in Diagonal Bio AB rights issue commences today
Mon, Apr 08, 2024 08:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, ... |
| 03.04.2024 | Diagonal Bio AB publishes a prospectus because of upcoming rights issue | Diagonal Bio AB publishes a prospectus because of upcoming rights issue
Wed, Apr 03, 2024 18:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, ... |
| 12.03.2024 | BoMill Board of Directors proposes a secured new share issue of maximum SEK 16.8 million to take the next step in further scaling up the commercialization of BoMill InSight | BoMill Board of Directors proposes a secured new share issue of maximum SEK 16.8 million to take the next step in further scaling up the commercialization of BoMill InSight
Tue, Mar 12, 2024 08:30 CET Report this content
THIS PRESS RELEASE ... |
| 19.02.2024 | Per Lindberg BidCo AB makes public the Offer Document regarding the mandatory bid for Ranplan Group AB | Per Lindberg BidCo AB makes public the Offer Document regarding the mandatory bid for Ranplan Group AB
Mon, Feb 19, 2024 18:52 CET Report this content
2024-02-19
NOTE: The Swedish version of this press release takes precedence over any othe... |
| 30.10.2023 | The subscription period in Crunchfish's rights issue ends on November 1st, 2023 | The subscription period in Crunchfish's rights issue ends on November 1st, 2023
Mon, Oct 30, 2023 08:30 CET Report this content
The last day to subscribe for shares in Crunchfish AB's ("Crunchfish" or the "Company") righ... |
| 18.10.2023 | The subscription period in Crunchfish’s rights issue begins today | The subscription period in Crunchfish’s rights issue begins today
Wed, Oct 18, 2023 08:30 CET Report this content
Today, October 18, 2023, the subscription period in Crunchfish AB’s (“Crunchfish” or the “Company”) rights issue of approximat... |
| 21.09.2023 | Last day for subscription in the ongoing rights issue | Last day for subscription in the ongoing rights issue
Thu, Sep 21, 2023 08:45 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANAD... |
| 12.09.2023 | The subscription period in the rights issue begins today | The subscription period in the rights issue begins today
Tue, Sep 12, 2023 08:45 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CA... |
| 08.09.2023 | Clean Industry Solutions Holding Europe AB (publ) publishes prospectus in connection with the rights issue | Clean Industry Solutions Holding Europe AB (publ) publishes prospectus in connection with the rights issue
Fri, Sep 08, 2023 15:00 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDI... |
| 26.07.2023 | Cline Scientific: Cline has reached the minimum limit in the ongoing rights issue | Cline Scientific: Cline has reached the minimum limit in the ongoing rights issue
Wed, Jul 26, 2023 14:27 CET Report this content
The board of Cline Scientific AB can today state that the minimum limit in the ongoing rights issue of SEK 5.5... |
| 14.07.2023 | The current subscription period is extended to July 17 | The current subscription period is extended to July 17
Fri, Jul 14, 2023 08:42 CET Report this content
The Board of Cline Scientific AB has decided to extend the subscription period in the ongoing rights issue. The extension applies until M... |
| 11.07.2023 | Cline Scientific: The new issue closes on July 12 | Cline Scientific: The new issue closes on July 12
Tue, Jul 11, 2023 14:37 CET Report this content
Cline Scientific AB's Rights Issue closes tomorrow, July 12. The rights issue gives existing shareholders the right to subscribe for two new s... |
| 26.06.2023 | Cline Scientific: Cline Scientific AB's rights issue begins today | Cline Scientific: Cline Scientific AB's rights issue begins today
Mon, Jun 26, 2023 08:30 CET Report this content
Today begins the rights issue in Cline Scientific AB. The issue is carried out on terms of 2:1, which means that for each exis... |
| 22.06.2023 | Cline Scientific: Cline Scientific AB publishes memorandum regarding the Rights Issue | Cline Scientific: Cline Scientific AB publishes memorandum regarding the Rights Issue
Thu, Jun 22, 2023 08:36 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRA... |
| 20.06.2023 | OmniCar Holding AB publishes issuing memorandum regarding the upcoming rights issue | OmniCar Holding AB publishes issuing memorandum regarding the upcoming rights issue
Tue, Jun 20, 2023 14:01 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OR ANY JURIS... |
| 19.06.2023 | Correction: Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million | Correction: Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million
Mon, Jun 19, 2023 08:52 CET Report this content
Press Release, 19 June 2023
The previous press release was inadvertently pub... |
| 19.06.2023 | Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million | Realheart Publishes Prospectus in Connection With Rights Issue of Units of Approximately SEK 56 Million
Mon, Jun 19, 2023 08:30 CET Report this content
Press Release 19 June, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN ... |
| 12.06.2023 | Cline Scientific: Cline decides on a share issue | Cline Scientific: Cline decides on a share issue
Mon, Jun 12, 2023 08:30 CET Report this content
INFORMATION IN THIS PRESS RELEASE MAY NOT BE PUBLISHED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA... |
| 26.05.2023 | DanCann Pharma A/S has secured 71 percent of the TO 2’s | DanCann Pharma A/S has secured 71 percent of the TO 2’s
Fri, May 26, 2023 08:30 CET Report this content
COPENHAGEN, Denmark, 26 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"... |
| 16.05.2023 | DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today | DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today
Tue, May 16, 2023 09:00 CET Report this content
COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Com... |
| 15.05.2023 | DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set | DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set
Mon, May 15, 2023 17:00 CET Report this content
COPENHAGEN, Denmark, 15 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "... |
| 19.04.2023 | The subscription period in BoMill’s rights issue begins today | The subscription period in BoMill’s rights issue begins today
Wed, Apr 19, 2023 09:15 CET Report this content
Today, April 19, 2023, the subscription period commences in BoMill AB’s (“BoMill” or the “Company”) rights issue of a maximum of 4... |
| 19.04.2023 | The last day of the subscription period in GomSpace’s rights issue | The last day of the subscription period in GomSpace’s rights issue
Wed, Apr 19, 2023 12:40 CET Report this content
Today, 19 April 2023, is the last day of the subscription period in GomSpace Group AB's (publ) ("GomSpace" or the &... |
| 19.04.2023 | Sista dagen av teckningsperioden i GomSpace företrädesemission | Sista dagen av teckningsperioden i GomSpace företrädesemission
Wed, Apr 19, 2023 12:40 CET Report this content
Idag den 19 april 2023 är sista dagen av teckningsperioden i GomSpace Group AB:s (publ) (”GomSpace” eller ”Bolaget”) företrädesem... |
| 17.04.2023 | Cline Scientific: Cline is carrying out a new share issue | Cline Scientific: Cline is carrying out a new share issue
Mon, Apr 17, 2023 13:15 CET Report this content
The board of Cline Scientific AB (“Cline” or “The Company”) has, with the support of the authorization from the annual general meeting... |
| 12.04.2023 | BoMill publishes prospectus regarding the rights issue | BoMill publishes prospectus regarding the rights issue
Wed, Apr 12, 2023 16:49 CET Report this content
Today BoMill AB (”BoMill” or the “Company”) has published a prospectus regarding the preferential rights issue of shares resolved by the ... |
| 29.03.2023 | Stayble Therapeutics AB publishes supplementary prospectus regarding the rights issue | Stayble Therapeutics AB publishes supplementary prospectus regarding the rights issue
Wed, Mar 29, 2023 13:25 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRA... |
| 28.03.2023 | StaybIe Therapeutics AB receives additional underwriting commitments for the ongoing rights issue | StaybIe Therapeutics AB receives additional underwriting commitments for the ongoing rights issue
Tue, Mar 28, 2023 17:40 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ST... |
| 24.03.2023 | Today the subscription period of StaybIe Therapeutics AB’s rights issue starts | Today the subscription period of StaybIe Therapeutics AB’s rights issue starts
Fri, Mar 24, 2023 09:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JA... |
| 23.03.2023 | StaybIe Therapeutics AB receives additional pre-subscription and underwriting commitments for the upcoming rights issue | StaybIe Therapeutics AB receives additional pre-subscription and underwriting commitments for the upcoming rights issue
Thu, Mar 23, 2023 21:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN... |
| 22.02.2023 | REMINDER: HEART TO1 Redemption Period Coming to an end | REMINDER: HEART TO1 Redemption Period Coming to an end
Wed, Feb 22, 2023 08:30 CET Report this content
Press Release 22 February, 2023
February 24 is the last day for trading in warrants of series TO1 in Scandinavian Real Heart AB ("Re... |
| 17.02.2023 | MEEW A/S RECEIVES APPROVAL FOR LISTING ON SPOTLIGHT STOCK MARKET AND PUBLISHES MEMORANDUM | MEEW A/S RECEIVES APPROVAL FOR LISTING ON SPOTLIGHT STOCK MARKET AND PUBLISHES MEMORANDUM
Fri, Feb 17, 2023 17:39 CET Report this content
MeeW A/S (“MeeW” or the “Company”) hereby announces that Spotlight Stock Market has given its approval... |
| 31.01.2023 | Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36 | Correction: the Subscription Price for Realhearts Warrant TO1 is SEK 2.36
Tue, Jan 31, 2023 10:49 CET Report this content
Press Release 31 January, 2023
Scandinavian Realheart AB ("Realheart" or the "Company"), issued du... |
| 30.01.2023 | Information on Trading and Exercise of Warrants of Series TO1 in Realheart | Information on Trading and Exercise of Warrants of Series TO1 in Realheart
Mon, Jan 30, 2023 17:09 CET Report this content
Press Release 30 January, 2023
Scandinavian Realheart AB ("Realheart" or the "Company"), issued d... |
| 05.12.2022 | The exercise period for Crunchfish’s warrants of series TO9 commences today | The exercise period for Crunchfish’s warrants of series TO9 commences today
Mon, Dec 05, 2022 08:30 CET Report this content
Crunchfish AB (“Crunchfish” or the “Company”) conducted a unit issue of shares and warrants of series TO9 in October... |
| 25.11.2022 | Safeture AB meddelar sista dag för handel med BTA | Safeture AB meddelar sista dag för handel med BTA
Fri, Nov 25, 2022 09:51 CET Report this content
Safeture AB:s, org. nr. 556776-4674, (”Safeture” eller ”Bolaget”), företrädesemission av aktier, vars teckningsperiod avslutades den 11 novemb... |
| 15.11.2022 | Safeture AB:s företrädesemission övertecknad | Safeture AB:s företrädesemission övertecknad
Tue, Nov 15, 2022 11:30 CET Report this content
Teckningsperioden i Safeture AB:s (publ) (”Safeture” eller ”Bolaget”) företrädesemission av aktier, i vilken även allmänheten gavs möjlighet att te... |
| 31.10.2022 | DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today | DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today
Mon, Oct 31, 2022 08:45 CET Report this content
COPENHAGEN, Denmark, October 31, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or... |
| 07.09.2022 | CS MEDICA A/S warrant exercise registered with the Danish Companies Registration Office | CS MEDICA A/S warrant exercise registered with the Danish Companies Registration Office
Wed, Sep 07, 2022 19:02 CET Report this content
On Thursday, 1 September 2022, the exercise period for CS MEDICA A/S (“CS MEDICA” or the “Company”) warr... |
| 06.09.2022 | CS MEDICA A/S raises approx. DKK 9.9 million through warrant exercise | CS MEDICA A/S raises approx. DKK 9.9 million through warrant exercise
Tue, Sep 06, 2022 08:45 CET Report this content
During the period 18 August 2022 – 1 September 2022, holders of warrants of series TO 1 have been entitled to subscribe fo... |
| 26.08.2022 | Last day of trading in warrants of series TO 1 is 30 August 2022 | Last day of trading in warrants of series TO 1 is 30 August 2022
Fri, Aug 26, 2022 08:00 CET Report this content
Tuesday, 30 August 2022, is the last day of trading in CS MEDICA A/S’s (“CS MEDICA” or the “Company”) warrants of series TO 1 o... |
| 23.08.2022 | The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today | The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today
Tue, Aug 23, 2022 08:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STAT... |
| 18.08.2022 | The exercise period for warrants of series TO 1 begins today | The exercise period for warrants of series TO 1 begins today
Thu, Aug 18, 2022 09:00 CET Report this content
Today, 18 August 2022, marks the beginning of the exercise period for warrants of series TO 1, that were issued in connection with ... |
| 16.08.2022 | Clinical Laserthermia Systems AB (publ) publishes prospectus relating to the rights issue | Clinical Laserthermia Systems AB (publ) publishes prospectus relating to the rights issue
Tue, Aug 16, 2022 16:55 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF... |
| 27.05.2022 | Loyal Solutions announces the outcome of the exercise of warrants of series TO 1 | Loyal Solutions announces the outcome of the exercise of warrants of series TO 1
Fri, May 27, 2022 19:11 CET Report this content
On Wednesday, 25 May 2022, the exercise period for Loyal Solutions A/S (“Loyal Solutions” or the “Company”) war... |
| 20.05.2022 | Last day of trading in warrants of series TO 1 is 23 May 2022 | Last day of trading in warrants of series TO 1 is 23 May 2022
Fri, May 20, 2022 09:14 CET Report this content
Monday, 23 May 2022, is the last day of trading in Loyal Solutions A/S’s (“Loyal Solutions” or the “Company”) warrants of series T... |
| 04.05.2022 | The exercise period for warrants of series TO 1 begins today | The exercise period for warrants of series TO 1 begins today
Wed, May 04, 2022 09:04 CET Report this content
Today, 4 May 2022, marks the beginning of the exercise period for the warrants of series TO 1 in Loyal Solutions A/S (“Loyal Soluti... |
| 26.04.2022 | BoMill publishes information memorandum regarding the Rights Issue | BoMill publishes information memorandum regarding the Rights Issue
Tue, Apr 26, 2022 08:00 CET Report this content
BoMill AB (publ) (”BoMill” or the “Company”) today publishes an information memorandum by reason of the proposed preferential... |
| 20.04.2022 | Today, trade commences in the Katalysen Ventures AB (publ) share on Spotlight Stock Market | Today, trade commences in the Katalysen Ventures AB (publ) share on Spotlight Stock Market
Wed, Apr 20, 2022 12:38 CET Report this content
Today, trade commences in the Katalysen Ventures AB (publ) (“Katalysen” or “the Company”) share on Sp... |
| 12.04.2022 | Katalysen Ventures AB (publ) announces oversubscribed listing issue | Katalysen Ventures AB (publ) announces oversubscribed listing issue
Tue, Apr 12, 2022 16:20 CET Report this content
On April 10, 2022, the subscription period in Katalysen Ventures AB's (publ) ("Katalysen" or "the Company&quo... |
| 06.04.2022 | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of signed subscription commitments in ongoing listing issue | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of signed subscription commitments in ongoing listing issue
Wed, Apr 06, 2022 08:59 CET Report this content
Katalysen Ventures AB (publ) ("Katalysen" or &... |
| 05.04.2022 | Katalysen Ventures AB (publ) signs subscription commitments in ongoing listing issue | Katalysen Ventures AB (publ) signs subscription commitments in ongoing listing issue
Tue, Apr 05, 2022 11:09 CET Report this content
Katalysen Ventures AB (publ) (“Katalysen” or “the Company”) hereby announces that the Company has signed su... |
| 04.04.2022 | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of new cooperation agreement | Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of new cooperation agreement
Mon, Apr 04, 2022 16:29 CET Report this content
Katalysen Ventures AB (publ) ("Katalysen" or "the Company") hereby ... |
| 01.04.2022 | SynAct publishes prospectus in connection with a fully guaranteed rights issue | SynAct publishes prospectus in connection with a fully guaranteed rights issue
Fri, Apr 01, 2022 14:59 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, A... |
| 29.03.2022 | ANNOUNCING REDUCED TRANSACTION COST IN RELATION TO IPO OFFER | ANNOUNCING REDUCED TRANSACTION COST IN RELATION TO IPO OFFER
Tue, Mar 29, 2022 17:50 CET Report this content
On 24 March 2022, Katalysen Ventures AB (publ)’s investment memorandum was approved by Spotlight Stock Market. In this investment m... |
| 28.03.2022 | SynAct resolves on a fully guaranteed rights issue of approximately SEK 150 million | SynAct resolves on a fully guaranteed rights issue of approximately SEK 150 million
Mon, Mar 28, 2022 07:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERI... |
| 25.03.2022 | The subscription period in Katalysen Ventures AB (publ) share issue starts today | The subscription period in Katalysen Ventures AB (publ) share issue starts today
Fri, Mar 25, 2022 08:50 CET Report this content
Today, 25 March 2022, is the first day of the subscription period in Katalysen Ventures AB (publ)’s (”Katalysen... |
| 24.03.2022 | Katalysen Ventures AB (publ) receives approval for listing and publishes memorandum | Katalysen Ventures AB (publ) receives approval for listing and publishes memorandum
Thu, Mar 24, 2022 10:13 CET Report this content
Katalysen Ventures AB (publ) (“Katalysen” or the ”Company”) hereby announces that the Company has been appro... |
| 17.03.2022 | Today Is The Last Day Of The Subscription Period In Bawat Water Technologies AB | Today Is The Last Day Of The Subscription Period In Bawat Water Technologies AB
Thu, Mar 17, 2022 10:17 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITE... |
| 23.02.2022 | Flat Capital offentliggör prospekt i samband med företrädesemission om cirka 190 MSEK och bjuder in till digital aktieägarträff den 8 mars | Offentliggörande av Prospektet
För fullständig information om företrädesemissionen hänvisas till det Prospekt som har upprättats och idag har godkänts av Finansinspektionen. Prospektet finns tillgängligt på Bolagets hemsida, Augment Partner... |
| 22.12.2021 | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments Wed, Dec 22, 2021 13:07 CET
During the period 25 November – 16 December 2021, holders of TO 1 have been entitled to ... |
| 22.12.2021 | Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments | During the period 25 November - 16 December 2021, holders of TO 1 have been entitled to subscribe for shares with warrants. A total of 2,432,535 warrants were exercised, corresponding to 2,432,535 shares and an overall exercise rate of appr... |
| 14.12.2021 | Last day of trading in Cessatech’s warrants of series TO 1 is today Tuesday 14 December 2021 | Last day of trading in Cessatech’s warrants of series TO 1 is today Tuesday 14 December 2021 Tue, Dec 14, 2021 08:00 CET
Copenhagen, Denmark, 14 December 2021 – Tuesday, 14 December 2021, is the last day of trading in warrants of series TO ... |
